Canonical: https://ownershiptrace.com/13f/companies/3307

# Who owns Eikon Therapeutics, Inc. (EIKN)? Elite investor 13F holders

3 tracked elite investors reported holding Eikon Therapeutics, Inc as of 2026-06-30, including Polen Capital Management, Renaissance Technologies LLC, Tudor Investment. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Polen Capital Management](https://ownershiptrace.com/13f/investors/61) | EIKON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-04 00:00:00 | 466433.00 USD | 35742.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1034524/0001172661-26-003035-index.html) |
| [Renaissance Technologies LLC](https://ownershiptrace.com/13f/investors/63) | EIKON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 349701.00 USD | 26797.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1037389/0001037389-26-000059-index.html) |
| [Tudor Investment](https://ownershiptrace.com/13f/investors/94675) | EIKON THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 195750.00 USD | 15000.000000 | Shares | hold | [Original filing](https://www.sec.gov/Archives/edgar/data/923093/0000902664-26-003485-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)